TI
BIOA

Trexquant Investment’s BioAge Labs BIOA Stock Holding History

Trexquant Investment’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
60,572
+21,238
+54% +$409K 0.01% 1210
2025
Q4 		$520K Buy
+39,334
New +$349K ﹤0.01% 1337

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Trexquant Investment's BIOA Position: Q1 2026 in Review

Trexquant Investment increased its BioAge Labs (BIOA) stake by 54% in Q1 2026, buying an estimated $409K and bringing the position to 60,572 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #1210.

Trexquant Investment first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Trexquant Investment held 60,572 shares of BioAge Labs worth $1.06M as of Q1 2026.
  • Trexquant Investment bought 21,238 BioAge Labs shares in Q1 2026, an estimated $409K.
  • BioAge Labs made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1210 holding.
  • Trexquant Investment first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.